The Nutritional Supplement Professionals
   
Sign In
My Shopping Cart: 0 items
Product Quick Search
Choose any or all
More Search Options >

Quick Order
Enter product code

Library Quick Search
Advanced Search >

The "Willner Window" Radio Show. Your source of nutritional supplement information and interviews, weekly, for 18 years. Listen to archived mp3 audio files.


View Current Catalog / Newsletter

View Previous Publications
Reference Library>

Reference Library

Nutritional Supplements Effective in improving cognitive performance, preventing age-related mental decline and reducing risk of dementia and Alzheimer’s disease.

Nutritional Supplements Effective in improving cognitive performance, preventing age-related mental decline and reducing risk of dementia and Alzheimer’s disease.

Can nutritional supplements reduce your risk of Alzheimer’s disease, dementia, and age-related mental decline? Theoretically, this should be the case. It is clear that certain nutrients affect the brain in ways that would be expected to enhance its function and health. Certain nutrients, herbs and essential oils might be expected to counter those factors we believe are responsible for conditions such as Alzheimer’s disease, as well as exerting a general anti-aging action.

While some research supports this, the results so far are not consistent, one way or the other. It would certainly be great if every study yielded positive results, but the fact that this is not the case may not be as discouraging as you might think. For one thing, the researchers are not discouraged. Promising research is active and ongoing in the Pharmaceutical industry. Derivatives of curcumin, for example, have shown promise as an anti-Alzheimer’s treatment.

A recent study piqued my interest. A nutritional supplement was shown to improve mild cognitive impairment. The study was published in the Journal of Alzheimer's Disease; 2015, Vol. 48, No. 3, 591-5. The same nutritional supplement had been utilized in previous studies, and has been shown to be effective, also, for individuals without cognitive impairment and with Alzheimer’s disease. Here is a summary of the most recent study:

“In this new, one-year study, people with mild cognitive impairment improved after taking a nutraceutical formula containing 30 IU vitamin E, 400 mcg folic acid, 6 mcg vitamin B12, 600 mg n-acetyl l-cysteine, 500 mg acetyl l-carnitine, and 400 mg SAMe per day. Half the 34 participants, average age 66, took a placebo for six months, then the entire group took the nutrient formula for another six months.

“Cognitive impairment involves memory, orientation, judgment, problem solving, personal care and other functions. Testing for these functions every three months, doctors found that the nutrient group improved significantly while the placebo group did not change.
In a second quarterly test of executive function, participants were asked to draw a clock as accurately as possible; a common way doctors assess the progression of Alzheimer's disease. During the placebo phase, performance declined, but in all nutrient phases, participants were able to maintain or improve performance of the clock-drawing task.”

An abstract, and link to the full pdf of the study can be found here. http://www.emailbliss.com/article.aspx?artid=324

(This product, by the way, is available under the name “Perceptiv.” It is available at Willner Chemists, in a 60 Tablet size, code number 62260, on sale at 33% off list price, for a limited time. (List Price: $79.95 ~ Sale Price: $53.95)
http://www.emailbliss.com/products.aspx?pid=62260

There are several possible reasons why, in spite of these positive results, other studies have mixed results. Dr. Michael Murray, in his recent newsletter, comments on this. If you do not already receive Dr. Murray’s email newsletter, I urge you to subscribe to it. Just go to www.doctormurray.com and sign up for his Natural Facts newsletter. Here is what he had to say:

New Research Shows Synergy With Omega-3 Fatty Acids And B Vitamins In Preventing Alzheimer's Disease

The human brain is a marvelously complex system that requires a wide range of nutrients to function properly. Intelligence, memory, behavior and concentration are all influenced by proper brain nutrition. Young or old, our nutritional status plays a vital role in determining how well our brain functions.

One of the problems with medical research is the obsession with identifying the impact of single factors and their impact on human health. When it comes to nutrition and the brain, this sort of line of research is a silly approach. A new study out of Oxford University highlights just how important it is to look and the interplay between just two key brain nutrients – omega-3 fatty acids and B vitamins – and there ability to prevent age-related mental decline.

Background Data:

A very large body of scientific evidence has shown that intelligence, memory, behavior and concentration are all influenced by proper brain nutrition. But, for the most part, this research has looked at individual factors and not their interactions. For example, a 2014 study conducted at Oxford's Department of Clinical Neurosciences involved with 156 elderly patients who had mild cognitive impairment and a high risk of dementia and Alzheimer's disease. The patients were divided into two groups: one group took a daily supplement with 800 micrograms of folic acid, 20 milligrams of vitamin B6, and 500 micrograms of vitamin B12; the other group took a placebo supplement.

Before the trial and during the testing period, the researchers utilized magnetic resonance imaging (MRI) to measure the patients' atrophy levels of grey matter in their brains. Atrophying (shrinking) grey matter is a sign of the progression of Alzheimer's disease and other forms of dementia.

Upon completion of the two-year study, researchers found that those given the B vitamin supplement had about seven times less grey matter shrinkage than did the placebo group. The researchers also found that those whose grey matter shrunk fastest had higher levels of homocysteine, and those with higher homocysteine levels initially received the greatest benefit from the B vitamin supplements.

In their conclusion the researchers stated: "Our results show that B-vitamin supplementation can slow the atrophy of specific brain regions that are a key component of the Alzheimer disease process and that are associated with cognitive decline."

Another key nutritional factor for proper brain function are the long chain omega-3 fatty acids EPA and DHA found in fish and fish oil supplements. The importance of omega-3 fatty acids to brain function relates to their role in the phospholipid composition of nerve cell membranes.

 Studies have shown that EPA and DHA influence:

-The fluidity of brain cell membranes.
-Neurotransmitter synthesis.
-Neurotranmitter binding.
-Signal transmission.
-The activity of key enzymes that break down neurotransmitters like serotonin, epinephrine, dopamine, and norepinephrine.

Clinical studies with supplemental EPA+DHA from fish oils in patients with a variety of psychological conditions including attention deficit disorder (ADD) and depression validate the importance of supplementation to boost EPA+DHA levels. Fish oils also appear to be important in protecting against age-related mental decline and Alzheimer's disease.

New Data:

While research has already established that B vitamin supplements and omega-3 fatty acids can help slow mental decline in older people with memory problems, the interaction between these two nutritional approaches has never really been examined until now. An international team led by Oxford University and United Arab Emirates University has now found that having higher levels of omega-3 fatty acids in the brain boost the benefits of B vitamins in mild cognitive function.

The team studied more than 250 people with mild cognitive impairment (MCI) in Oxford. MCI reflects an intermediate stage between the expected cognitive decline of normal aging and the more serious decline of dementia. People with mild cognitive impairment can have problems with memory, language, thinking and judgment, but generally not to a degree to cause significant problems in their day-to-day life and usual activities.

Mild cognitive impairment may increase the risk of later progressing to Alzheimer's disease or other dementia, but not everyone with Mild cognitive impairment progresses to dementia.

At the start of the study, each person was given a set of tests to measure their cognition, and had a blood test to determine the levels of the omega-3 fatty acids EPA and DHA in the their blood. The participants were split into two randomly selected groups, who received either a B-vitamin supplement or a placebo pill over two years. Their cognitive performance was also measured and the results compared with the baseline results from the start of the study.

What the researchers found was that for people with low levels of EPA+DHA, the B vitamin supplement had little to no effect. But for those with high baseline EPA+DHA levels, the B vitamins were very effective in preventing cognitive decline compared to the placebo. These results are game changing because they show a clear interaction and that B vitamins only slow the rate of brain atrophy in Mild cognitive impairment in those with a good level of EPA+DHA.

The team of researchers are now designing a study to actually test the combination of B vitamins and EPA+DHA in slowing the conversion from Mild cognitive impairment to Alzheimer's disease.

Commentary:

Here is something that is very important to for people to know. Drugs do not work to improve Mild cognitive impairment. In a systemic review funded by the Drug Efficacy and Safety Network of the Canadian Institute of Health Research, eight randomized clinical trials and 3 companion reports were used to evaluate the safety and efficacy of various drugs referred to as "cognitive enhancers" (donepezil [Aricept], rivastigmine [Exelon], galantamine [Razadyne], or memantine [Nemenda]) on mild cognitive impairment.

Results showed these drugs did NOT improve cognition or function among patients with Mild cognitive impairment and were associated with a greater risk of side effects especially nausea, diarrhea and vomiting than placebo. Researchers concluded "Our findings do not support the use of cognitive enhancers for mild cognitive impairment."

The bottom line is that the key goal to boosting brain function is to bath the brain in "super nutrition," as numerous studies have shown that brain function is directly related to nutritional status. High nutritional status equals higher mental function.

The key dietary factors that reduce the risk of dementia and Alzheimer's disease from population-base studies are higher fish consumption (and omega-3 fatty acids), monounsaturated fatty acids (primarily from olive oil), light to moderate alcohol use (primarily red wine), and increased non-starchy vegetable and fruit consumption. It is likely that it is the combination of all of these factors that provide the highest degree of protection versus any single dietary factor.

One food that is particularly helpful are blueberries or blueberry extracts. In animal studies researchers have found that blueberries help protect the brain from oxidative stress and memory loss.

In addition to diet, it makes sense to take a high potency multiple vitamin and mineral formula to supply the brain with super nutrition it makes sense to also take 1,000 to 3,000 mg of EPA and DHA (combined) from a quality fish oil. Higher intakes of these omega-3 fatty acids are associated with higher mood and mental function scores.

If symptoms of mental deterioration are definitely present in a person 50 years and older I would recommend taking phosphatidylserine. Phosphatidylserine (PS) is a critical nutrient for anyone with impaired mental function. PS plays a major role in determining the integrity and fluidity of brain cell membranes. Over a dozen double-blind studies have shown phosphatidylserine to improve in mental function, mood, and behavior in patients with degenerative brain disorders. The recommended dosage is 100 mg three times daily.

Reference:

Oulhaj A, Jernerén F, Refsum H, Smith AD, de Jager CA. Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment. J Alzheimers Dis. 2016 Jan 6;50(2):547-57.

Additional Comments . . . from Don Goldberg
If you are concerned about cognitive function, mild cognitive impairment, Alzheimer’s disease, etc, and would like to optimize your diet and/or nutritional supplement regimen accordingly, the pharmacists and nutritionists at Willner Chemists will be happy to assist you.


                            
                                   

print this page


Disclaimer

The information provided on this site, or linked sites, is provided for informational purposes only, and should not be used as a substitute for advice from your physician or other health care professional. Product information contained herein has not necessarily been evaluated or approved by the U.S. Food and Drug Administration, and is not intended to diagnose, treat, cure or prevent disease.




Willner Chemists Retail Locations
100 Park Ave, New York, NY 10017
1-800-633-1106 or 1-212-682-2817 | FAX: 1-212-682-6192

?2020 Willner Chemists | Contact Us | Join Mailing List | Site Map | Privacy Policy | Terms & Conditions | Site Credits

 

星空影院-星空影院电视免费播放-星空影院a片在线播放